Overview

Pharmacokinetic Study of 48-hour Sevoflurane Inhalation Using a Disposable Delivery System (AnaConDa©) in ICU Patients With Acute Kidney Injury

Status:
Unknown status
Trial end date:
2016-03-01
Target enrollment:
0
Participant gender:
All
Summary
Describing a pharmacokinetic model of 48-h sevoflurane sedation in ICU patients with acute kidney failure
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University Hospital, Clermont-Ferrand
Treatments:
Sevoflurane
Criteria
Inclusion Criteria:

- Adult patients ventilated more than 48 h Stable respiratory and hemodynamic conditions
Consent of patients or family Arterial line AKIN score = 3

Exclusion Criteria:

- BMI <30 Sevoflurane anaphylaxia